Professor Zvia Agur is an eminent international biomathematician, who has made major contributions to the theory of disease dynamics, chemotherapy and vaccination policies optimization. Prof. Agur is founder of the Institute for Medical BioMathematics (IMBM), has been the president of the Israeli Society of Theoretical and Mathematical Biology, a member of the Board of Directors of the European Society of Mathematical and Theoretical Biology, and an editor of several professional publications. Her innovative research work has won national awards, has been published in a long line of leading scientific journals and is recognized by the academic community worldwide. Prof. Agur holds a Ph.D. from the Hebrew University in Jerusalem and the Université Libre in Brussels.

Karin holds a Ph.D. degree in Molecular Biology from the Weizmann Institute of Science Rehovot. Her Ph.D. thesis, in the field of molecular and cellular biology, focused on the proto-oncogene c-Myc as a transcription factor and inducer of apoptosis and on the control of c-Myc degradation. She worked for more than ten years in biotechnology start-up companies in the fields of drug discovery and drug development. Karin joined IMBM in January 2008.

Vladimir is a Medical Doctor at the Hadassah Medical Center in Jerusalem. He holds a B.Sc. degree in Medical Sciences from the Hebrew University, M.D. degree from the Hebrew University & Hadassah Medical School, and an M.Sc. degree from the Department of Experimental Medicine and Cancer Research in the faculty of Medicine at the Hebrew University of Jerusalem. His M.Sc. research, carried out under the supervision of Prof. S.A. Ben-Sasson, involved the use of pathway inhibitors for the C-terminal post-translational modification of proteins, as a possible avenue for developing anti-angiogenesis therapy. Dr Vainstein successfully finished residency in Internal medicine Department at Hadassah Medical Center Campus Mt Scopus, Jerusalem, and fellowship in Hematology Department at Hadassah Medical Center, Ein Kerem, Jerusalem. In IMBM he took part in several projects including modeling human ganulopoiesis and chemotherapy-induced myelotoxicity, optimization of the immunotherapy of acute myeloid leukemia, and cancer stem cell modeling.

Gili has completed studies towards a Ph.D. degree in the field of theoretical chemistry, in the department of chemistry at Bar-Ilan University. Her thesis work, under the supervision of Prof. Kenneth G. Kay, included an analytical and numerical research in the area of semiclassical mechanics, using classical mechanics to approximate solutions to problems in quantum mechanics. Gili joined IMBM in January 2010, and she takes part in the Cancer Stem Cell project.

Moran joined IMBM in November 2004, after completing a B.Sc. in Computational Biology at Bar-Ilan University. In IMBM, Moran takes part in the Cancer Immunotherapy project. This year, she will also complete her PhD thesis work at the Institute for Drug Research, in the Faculty of Medicine at the Hebrew University of Jerusalem, under the supervision of Prof. Francesca Levi-Schaffer.

After completing his B.Sc. in Life Science and Mathematics at the Hebrew University of Jerusalem, Yuri spent two more years at the Hebrew University studying Near Field microscope applications to micro-manipulations in biophysics, under the supervision of Prof Aharon Lewis. Yuri holds an M.Sc. degree in Applied Mathematics from the Technion, Israel Institute of Technology. His M.Sc. study involved mathematical combustion theory. At IMBM, Yuri employs his skills in applied mathematics for developing mechanism-based models of cancer drug therapy and its accompanying physiological side effects.

Yuri holds a BA degree in Theoretical Mathematics from the Tel-Aviv University (TAU). Over many years of scientific research at IMBM, he has been involved in biomathematical modelling of several cancer diseases, as well as in researching cancer stem cells, intracellular signal transduction and clinical immunotherapy. His current research continues to focus on modelling cancer growth and treatment, in particular, immunotherapy of prostate cancer and glioblastomas, modelling of cancer stem cells, and modelling of intracellular signal transduction.

Ofir holds a B.Sc. degree from the department of applied mathematics in Holon institute for technology (H.I.T). He has majored in two fields: Biomathematics and signal processing. Ofir is currently perusing studies towards a M.Sc. degree in applied mathematics at TAU, focusing on proving that an artificially generated intrarcellular transport network (e.g microtubules) could be constructed such that it will be equivalent to the real one, for which the only available geometrical knowledge is its projection image, in the sense that a cytoplasmic entity travelling stochastically on and off it will have similar dynamics on both (under the supervision of Professor Eli Turkel).

Dorit is the Administrative Manager of IMBM. She holds a B.A. degree in English Literature and Information Science from Bar-Ilan University. Her primary responsibility in IMBM is providing quality services to ensure successful finance and personnel management of IMBM’s scientific and administrative members and visitors the latter include Israeli and foreign scientists and students, engineering trainees, as well as post-doctorate students at IMBM. In her work she also helps fellow researchers in retrieving information, builds IMBM's information center and is in charge of the institute' Internet site.

As the administrator of IMBM, a non-profit organization, Dorit is also in charge of IMBM’s “Amutah”, organizing board meetings, preparing board minutes, and presenting budget and annual reports to the organization’s lawyers and accountants. She organizes and oversees the logistical activities in the office, procurement activities and staff workload oversight.

About IMBM | Scientific Board | IMBM Members | Research Projects | Applications
Join Us | Press Release | Events | Publications | HOME